# Intranasal Dexmedetomidine on Blood Pressure in Elderly Hypertensive Patients Undergoing Cataract Surgery

> **NCT07080229** · PHASE3 · RECRUITING · sponsor: **Suez Canal University** · enrollment: 126 (estimated)

## Conditions studied

- Cataract
- Hypertension

## Interventions

- **DRUG:** Intranasal dexmedetomidine
- **DRUG:** Intranasal normal saline

## Key facts

- **NCT ID:** NCT07080229
- **Lead sponsor:** Suez Canal University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-16
- **Primary completion:** 2026-04
- **Final completion:** 2026-05
- **Target enrollment:** 126 (ESTIMATED)
- **Last updated:** 2026-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07080229

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07080229, "Intranasal Dexmedetomidine on Blood Pressure in Elderly Hypertensive Patients Undergoing Cataract Surgery". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07080229. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*